Sarepta Therapeutics (SRPT) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.69% |
| Dec 31, 2025 | -32.77% |
| Sep 30, 2025 | 19.70% |
| Jun 30, 2025 | -53.06% |
| Mar 31, 2025 | 61.41% |
| Dec 31, 2024 | -13.05% |
| Sep 30, 2024 | 17.95% |
| Jun 30, 2024 | -5.01% |
| Mar 31, 2024 | 17.03% |
| Dec 31, 2023 | 3.30% |
| Sep 30, 2023 | 6.84% |
| Jun 30, 2023 | 1.14% |
| Mar 31, 2023 | 5.39% |
| Dec 31, 2022 | 4.01% |
| Sep 30, 2022 | -7.49% |
| Jun 30, 2022 | 4.24% |
| Mar 31, 2022 | 4.84% |
| Dec 31, 2021 | -32.32% |
| Sep 30, 2021 | 7.42% |
| Jun 30, 2021 | 0.61% |
| Mar 31, 2021 | 10.35% |
| Dec 31, 2020 | -6.74% |
| Sep 30, 2020 | 11.90% |
| Jun 30, 2020 | 5.06% |
| Mar 31, 2020 | -93.03% |
| Dec 31, 2019 | -7.23% |
| Sep 30, 2019 | 4.91% |
| Jun 30, 2019 | 17.94% |
| Mar 31, 2019 | -14.51% |
| Dec 31, 2018 | -48.06% |
| Sep 30, 2018 | 16.47% |
| Jun 30, 2018 | 9.52% |
| Mar 31, 2018 | 2.79% |
| Dec 31, 2017 | -74.71% |
| Sep 30, 2017 | -105.23% |
| Jun 30, 2017 | 22.90% |
| Mar 31, 2017 | -22.80% |
| Dec 31, 2016 | 22.84% |
| Sep 30, 2016 | -595.38% |
| Jun 30, 2016 | 61.42% |
| Mar 31, 2016 | -68.72% |
| Dec 31, 2015 | 8.92% |
| Sep 30, 2015 | -12.15% |
| Jun 30, 2015 | 6.32% |
| Mar 31, 2015 | 54.79% |
| Dec 31, 2014 | -273.62% |
| Sep 30, 2014 | 47.26% |
| Jun 30, 2014 | 52.59% |
| Mar 31, 2014 | 14.77% |
| Dec 31, 2013 | 5.94% |
| Sep 30, 2013 | -71.87% |
| Jun 30, 2013 | 2.67% |
| Mar 31, 2013 | 10.52% |
| Dec 31, 2012 | -394.01% |
| Sep 30, 2012 | -55.11% |
| Jun 30, 2012 | 19.89% |
| Mar 31, 2012 | 23.38% |
| Dec 31, 2011 | 13.92% |
| Sep 30, 2011 | 14.45% |
| Jun 30, 2011 | -132.74% |
| Mar 31, 2011 | 30.68% |
| Dec 31, 2010 | 6.61% |
| Sep 30, 2010 | 2.11% |